Viking Therapeutics Stock Skyrockets on Promising Obesity Drug Trial Results

Investors in Viking Therapeutics, Inc. (NASDAQ: VKTX) woke up to an exhilarating surprise as the company’s stock price catapulted upwards by an impressive 35.67%, reaching a new high of $40.85. This remarkable surge, attributed to promising results from a recent obesity drug trial, has caught the attention of market analysts and investors alike. As competitors […]